
CONMED Corporation
CNMD
Updated: 24/09/2026, 16:43:05
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
No summaries found.
- Share price
- $45.52
- Market cap
- $1.36B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Patrick J. Beyer
- Employees
- 3,900
- IPO date
- 23/07/1987
- Beta
- 0.907
- Last dividend
- $0.00
- Day range
- $45.42 – $45.95
- 52-week range
- $31.44 – $53.66
- 1-day performance
- -0.61%
- 1-year performance
- 44.78%
- Current drawdown (1Y)
- -15.17%
- CIK
- 0000816956
- CUSIP
- 207410101
- ISIN
- US2074101013
- Created
- 07/12/2025, 03:23:25
- Last update
- 24/09/2026, 16:43:05
Track CONMED Corporation with an AI analyst
See which prediction-market events move CNMD, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report?
Zacks Investment Research • STOCK • 29/05/2026, 14:32:02
Is the Options Market Predicting a Spike in CONMED Stock?
Zacks Investment Research • STOCK • 14/05/2026, 14:01:23
CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up
Zacks Investment Research • STOCK • 30/04/2026, 11:05:34
CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 30/04/2026, 02:51:33
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research • STOCK • 29/04/2026, 22:30:17
Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research • STOCK • 29/04/2026, 21:42:21
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
Zacks Investment Research • STOCK • 09/04/2026, 14:22:18
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
Zacks Investment Research • STOCK • 10/03/2026, 12:56:10
Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue?
Zacks Investment Research • STOCK • 27/02/2026, 13:30:36